You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
17 September 2026 - German pharmaceutical and life sciences company Bayer AG (ETR:BAYN) (OTC:BAYRY) said on Thursday that the US Food and Drug Administration (FDA) has approved Kerendia (finerenone) to reduce urinary albumin-to-creatinine ratio in ad...
17 September 2026 - ProBio Inc, a global contract development and manufacturing organisation (CDMO) involved in biologics and cell and gene therapies (CGT), announced on Wednesday a strategic collaboration with clinical research organisation (CRO) Ku...
17 September 2026 - Myosin Therapeutics Inc, a clinical-stage biotechnology company developing a new class of therapies targeting cancer cell mechanics, announced on Thursday its selection as a 2026–2027 National Cancer Institute (NCI) Investor...
16 September 2026 - Healthcare technology company Medtronic (NYSE: MDT) announced on Wednesday that it has received US Food and Drug Administration clearance for its LigaSure RAS Maryland jaw device for use with the Hugo robotic-assisted surgery syst...
16 September 2026 - Jubilant Therapeutics Inc, a US-based clinical-stage biopharmaceutical company advancing precision therapies for hematological malignancies, announced on Tuesday the presentation of the first clinical data from its ongoing Phase 1...
16 September 2026 - Skyhawk Therapeutics Inc, a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate RNA targets, announced on Tuesday the final 15-month results from its Phase 1/2 clinical trial evaluat...
16 September 2026 - Colombian biotechnology company VaxThera S.A.S. and US-based Codagenix Inc, a clinical-stage biotechnology company focused on synthetic biology-based vaccines, announced on Tuesday an agreement on terms for VaxThera to exclusively...